Ecopia Named as One of Canada's Top Ten.Business Editors/Health/Medical Writers BIOWIRE2K BioNorth 2003 MONTREAL--(BUSINESS WIRE)--Oct. 8, 2003 -Ecopia BioSciences Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension : EIA (Electronic Industries Alliance, Arlington, VA, www.eia.org) A membership organization founded in 1924 as the Radio Manufacturing Association. It sets standards for consumer products and electronic components. ) is very pleased to announce that it has been named one of Canada's Top Ten Life Sciences Corporate Financing & Partnering Prospects by the Ottawa Life Sciences Council (OLSC OLSC Override, Limit & Status Check OLSC Ontario Library Services Centre (Kitchener, Canada) ). As part of this prestigious group, Ecopia will be presenting at a conference hosted by the OLSC, called BioNorth 2003, the 10th Annual Ottawa Life Sciences International Conference and Exhibition, on November 17th . Commenting on the award, Dr. Pierre Falardeau, President and Chief Executive Officer of Ecopia stated: "We are very proud to be one of the Top Ten finalists. We are honored to get such recognition for our hard work and commitment to make Ecopia into a premier biotechnology company in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. ." He added: "We are building around a technological approach that makes us one of the most innovative companies in the area of anti-infective drug discovery and development." Ecopia has developed an innovative and proprietary drug discovery platform designed to build a pipeline of new antibacterial antibacterial /an·ti·bac·te·ri·al/ (-bak-ter´e-al) destroying or suppressing growth or reproduction of bacteria; also, an agent that does this. an·ti·bac·te·ri·al adj. , antifungal and anticancer agents. The Company's pipeline includes two antifungal agents antifungal agents, n.pl agents that inhibit, control, or kill fungi. The most common yeastlike fungus occurring in or near the oral cavity is C. albicans. , ECO-02301 and ECO-14401, two anticancer agents, ECO-04601 and ECO-02201 and an antibacterial agent, ECO-00501. Ecopia's shares are listed on the Toronto Stock Exchange Toronto Stock Exchange (TSE) Canada's largest stock exchange, trading approximately 1,200 company stocks and 33 options. (ticker symbol Ticker Symbol An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors : EIA). This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. The forward-looking statements, including expectations as to the pharmaceutical potential of compounds discovered by the Company's platform, the timeframe for development of the compounds into new medications, and expansion of the Company's product pipeline involve risk and uncertainties. Actual events could differ materially from those projected here and depend on a number of factors, including scientific uncertainties relating to scientific hypotheses and experimental approaches in regard to the drug discovery platform, uncertainties related to the regulatory process for drug development and the success and timely completion of clinical studies and trials, and the impact of general economic conditions. Investors are cautioned against placing undue reliance on forward-looking statements. A more complete discussion of the risks and uncertainties facing the Company appears in Ecopia's 2002 Annual Report. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion